Target Price | $18.57 |
Price | $10.36 |
Potential |
79.26%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Arcutis Biotherapeutics Inc 2025 .
The average Arcutis Biotherapeutics Inc target price is $18.57.
This is
79.26%
register free of charge
$27.00
160.62%
register free of charge
$12.00
15.83%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend Arcutis Biotherapeutics Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arcutis Biotherapeutics Inc stock has an average upside potential 2025 of
79.26%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 59.61 | 166.56 |
1,515.45% | 179.42% | |
EBITDA Margin | -401.31% | -101.21% |
95.07% | 74.78% | |
Net Margin | -738.63% | -108.57% |
95.87% | 85.30% |
7 Analysts have issued a sales forecast Arcutis Biotherapeutics Inc 2024 . The average Arcutis Biotherapeutics Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Arcutis Biotherapeutics Inc EBITDA forecast 2024. The average Arcutis Biotherapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Arcutis Biotherapeutics Inc Analysts have issued a net profit forecast 2024. The average Arcutis Biotherapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.78 | -1.55 |
33.22% | 58.99% | |
P/E | negative | |
EV/Sales | 6.34 |
4 Analysts have issued a Arcutis Biotherapeutics Inc forecast for earnings per share. The average Arcutis Biotherapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Arcutis Biotherapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Arcutis Biotherapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.